Company intelligence / Profile preview

PT Global Onkolab Farma

Jakarta Timur, DKI Jakarta, Indonesialinkedin.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

PT Global Onkolab Farma specializes in the local manufacture and development of high-quality, affordable oncology drugs—including small molecules and monoclonal antibodies—for the Indonesian market. The company has launched at least one innovative immunotherapy product for lung cancer and collaborates with both local communities and international partners to expand access to modern cancer treatments. Clinical results are positive enough to support commercial launches such as Serplulimab for lung cancer patients in Indonesia.

Therapeutic areas
Oncology
Modalities
Small molecules (chemotherapy agents)Monoclonal antibodies (mAbs)ImmunotherapiesSupportive therapies/nutritionals
Industry
Biotech
02

Drug pipeline

3 assets

fluorodeoxyglucose F-18

Commercial
Indications
Cancer diagnosis

2 more assets in the full pipeline.

Request access →
03

Partnerships

KGbio/Henlius partnership for development/commercialization of Serplulimab immunotherapy across Southeast Asia, Middle East & North Africa regions.Collaboration with local Indonesian healthcare providers/cancer communities.

Beyond the preview

Go deeper on PT Global Onkolab Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PT Global Onkolab Farma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call